The Center translates basic discoveries into novel antimicrobial therapies to help resolve the Antimicrobial Resistance Crisis, a slow-moving pandemic, according to the WHO. combat Biowarfare and conventional pathogen threats. The Center is funded by grants from the NIH, The Schmidt Futures and the Steven & Alexandra Cohen Foundation.